Regulations.gov document
Reference 5 re: Agency Information Collection Activities; Proposed Collection; Comment…
Supporting & Related Material · FDA-2020-N-1307 · posted Jul 14, 2020
Key facts
| Document ID | FDA-2020-N-1307-0006 |
|---|---|
| Title | Reference 5 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2020-N-1307 |
| Posted | Jul 14, 2020 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: